Literature DB >> 14999771

Mutation analysis of the apoptotic "death-receptors" and the adaptors TRADD and FADD/MORT-1 in osteosarcoma tumor samples and osteosarcoma cell lines.

Markus J Dechant1, Jörg Fellenberg, Christian G Scheuerpflug, Volker Ewerbeck, Klaus-Michael Debatin.   

Abstract

Apoptosis is a key mechanism of the organism that regulates embryogenesis and development, maintains homeostasis of the immune system and removes potentially hazardous cells. A dysregulation of apoptosis signaling may thus disturb the balance of cell survival and cell death, leading to the development of several diseases including cancer. In order to determine whether osteosarcomas display an increased frequency of genetic alterations that affect apoptosis signaling, we analyzed the death domains of the death receptor genes CD95/Fas/Apo1, TNFR1, DR3/Apo3/WSL-1/LARD/TRAMP, DR5/TRAIL-R2/TRICK2/KILLER, DR6 and the complete coding sequences of the death receptor gene DR4/TRAIL-R1 and the genes of the adaptors TRADD and FADD/MORT-1. The investigation included 15 osteosarcoma tumor samples, 3 osteosarcoma cell lines (SAOS-2, HOS and MG63) and peripheral blood from 20 donors as controls. We were able to identify 4 different sequence variations within the DR4 gene located on exons 3, 4, 5 and 10 (death-domain). No alterations have been detected in the other genes or exons investigated. Except the sequence variant affecting exon 4, the alterations were homozygous in 15% of the tumor samples and cell lines, whereas the same alterations found in the control group were heterozygous or even not detectable. Three out of 4 alterations are located in the receptor's extracellular cysteine rich domain, which contains the ligand binding area and 1 on exon 10 coding for the death-domain. They may thus exert influence on ligand-receptor interactions and subsequent apoptosis induction. Our findings suggest that homozygous genetic alterations within the DR4 gene may be implicated in the formation of osteosarcoma. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14999771     DOI: 10.1002/ijc.20008

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis.

Authors:  Rachel M Locklin; Ermanno Federici; Belen Espina; Philippa A Hulley; R Graham G Russell; Claire M Edwards
Journal:  Mol Cancer Ther       Date:  2007-12-07       Impact factor: 6.261

2.  Clinical significance of expression of apoptotic signal proteins in gastric carcinoma tissue.

Authors:  Xin-Han Zhao; Shan-Zhi Gu; Hong-Gang Tian; Ping Quan; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

3.  Meloxicam Inhibits Apoptosis in Neurons by Deactivating Tumor Necrosis Factor Receptor Superfamily Member 25, Leading to the Decreased Cleavage of DNA Fragmentation Factor Subunit α in Alzheimer's Disease.

Authors:  Peipei Guan; Di Zhu; Pu Wang
Journal:  Mol Neurobiol       Date:  2022-10-24       Impact factor: 5.682

4.  Association of four polymorphisms in the death receptor 4 gene with cancer risk: an updated meta-analysis.

Authors:  Jing Lu; Qin Qin; Liang-Liang Zhan; Jia Liu; Hong-Cheng Zhu; Chi Zhang; Li-Ping Xu; Zhe-Ming Liu; Xi Yang; Hong-Yan Cheng; Xin-Chen Sun
Journal:  Tumour Biol       Date:  2014-02-05

5.  There is no significant association between death receptor 4 (DR4) gene polymorphisms and lung cancer in Turkish population.

Authors:  Deniz Taştemir-Korkmaz; Osman Demirhan; Sedat Kuleci; Serap Hastürk
Journal:  Pathol Oncol Res       Date:  2013-05-10       Impact factor: 3.201

6.  Targeting apoptosis signaling pathways for anticancer therapy.

Authors:  Simone Fulda
Journal:  Front Oncol       Date:  2011-08-27       Impact factor: 6.244

7.  Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level.

Authors:  Donia P Macartney-Coxson; Kylie A Hood; Hong-jun Shi; Teresa Ward; Anna Wiles; Rosemary O'Connor; David A Hall; Rod A Lea; Janice A Royds; Richard S Stubbs; Serena Rooker
Journal:  BMC Cancer       Date:  2008-07-01       Impact factor: 4.430

8.  The role of death receptor 3 in the biological behavior of hepatocellular carcinoma cells.

Authors:  You Cheng Zhang; Liu Qing Guo; Xiao Chen; Gen Nian Wang; Ri Ni; Man Cai Wang; Feng Xian Wei
Journal:  Mol Med Rep       Date:  2014-11-04       Impact factor: 2.952

Review 9.  Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs).

Authors:  Rama Rathore; Jennifer E McCallum; Elizabeth Varghese; Ana-Maria Florea; Dietrich Büsselberg
Journal:  Apoptosis       Date:  2017-07       Impact factor: 4.677

10.  Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy.

Authors:  Chiara Passarelli; Rita Selvatici; Alberto Carrieri; Francesca Romana Di Raimo; Maria Sofia Falzarano; Fernanda Fortunato; Rachele Rossi; Volker Straub; Katie Bushby; Mojgan Reza; Irina Zharaieva; Adele D'Amico; Enrico Bertini; Luciano Merlini; Patrizia Sabatelli; Paola Borgiani; Giuseppe Novelli; Sonia Messina; Marika Pane; Eugenio Mercuri; Mireille Claustres; Sylvie Tuffery-Giraud; Annemieke Aartsma-Rus; Pietro Spitali; Peter A C T'Hoen; Hanns Lochmüller; Kristin Strandberg; Cristina Al-Khalili; Ekaterina Kotelnikova; Michael Lebowitz; Elena Schwartz; Francesco Muntoni; Chiara Scapoli; Alessandra Ferlini
Journal:  Front Genet       Date:  2020-07-03       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.